المؤلفون: Andrea V Margulis, Marie Linder, Alejandro Arana, Anton Pottegård, Ina Anveden Berglind, Christine L Bui, Nina Sahlertz Kristiansen, Shahram Bahmanyar, Lisa J McQuay, Willem Jan Atsma, Kwame Appenteng, Milbhor D'Silva, Susana Perez-Gutthann, Jesper Hallas

المصدر: PLoS ONE, Vol 13, Iss 9, p e0204456 (2018)

مصطلحات موضوعية: Medicine, Science

وصف الملف: electronic resource

العلاقة: http://europepmc.org/articles/PMC6160033?pdf=renderTest; https://doaj.org/toc/1932-6203Test

الوصول الحر: https://doaj.org/article/5c7ff1827f6b40b49627f2619eafb006Test

المؤلفون: Andrea V. Margulis, Kwame Appenteng, Stefan de Vogel, Susana Perez-Gutthann, Lisa J. McQuay, Alejandro Arana, Cristina Varas-Lorenzo, Billy Franks, Maria Reynolds, Alicia Gilsenan, Christine L. Bui, Cristina Rebordosa

المصدر: Pharmacoepidemiology and Drug Safety

مصطلحات موضوعية: medicine.medical_specialty, obesity, validity, pharmacoepidemiology, Databases, Factual, Epidemiology, Myocardial Infarction, acute myocardial infarction, menopause, 030226 pharmacology & pharmacy, smoking, 03 medical and health sciences, 0302 clinical medicine, Predictive Value of Tests, Risk Factors, Original Reports, Medicine, Original Report, Humans, Pharmacology (medical), 030212 general & internal medicine, Myocardial infarction, cardiovascular diseases, Information bias, Stroke, business.industry, Medical record, Confounding, Gold standard, Pharmacoepidemiology, medicine.disease, stroke, United Kingdom, information bias, electronic record, Cohort, Emergency medicine, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aefbdd7294b78aca5dec79a7333a6482Test
http://europepmc.org/articles/PMC7821285Test

المؤلفون: Cheryl Enger, Libby Horter, Nina Sahlertz Kristiansen, Stefan de Vogel, Kelesitse Phiri, Brandon T. Suehs, Jesper Hallas, Alejandro Arana, Marie Linder, Ingvild Odsbu, Yihua Xu, Andrea V. Margulis, Kwame Appenteng, John D. Seeger, Morten Olesen, Veena Hoffman, Susana Perez-Gutthann

المصدر: Hoffman, V, Hallas, J, Linder, M, Margulis, A, Suehs, B T, Arana, A, Phiri, K, Enger, C, Horter, L, Odsbu, I, Olesen, M, Perez-Gutthann, S, Xu, Y, Kristiansen, N S, Appenteng, K, de Vogel, S, Seeger, J D & the mirabegron PMR-PASS study group 2021, ' Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder : Findings from a Non-Interventional, Multinational, Cohort Study ', Drug Safety, vol. 44, no. 8, pp. 899-915 . https://doi.org/10.1007/s40264-021-01095-7Test
Drug Safety

مصطلحات موضوعية: Male, medicine.medical_specialty, Population, Muscarinic Antagonists, Toxicology, Cohort Studies, Risk Factors, Internal medicine, medicine, Humans, Pharmacology (medical), Original Research Article, education, Stroke, Aged, Pharmacology, education.field_of_study, Proportional hazards model, business.industry, Urinary Bladder, Overactive, Hazard ratio, medicine.disease, Thiazoles, Treatment Outcome, Overactive bladder, Cardiovascular Diseases, Heart Disease Risk Factors, Acetanilides, Female, Treatments for overactive bladder, Mirabegron, business, medicine.drug, Cohort study

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::606ed98949016a3becf28423411ba054Test
https://findresearcher.sdu.dk:8443/ws/files/191412893/Hoffman2021_Article_CardiovascularRiskInUsersOfMir.pdfTest

المؤلفون: John D. Seeger, Marie Linder, Veena Hoffman, Alejandro Arana, Shahram Bahmanyar, Susana Perez-Gutthann, Jesper Hallas, Libby Horter, Brandon T. Suehs, Stefan de Vogel, Kelesitse Phiri, Nina Sahlertz Kristiansen, Andrea V. Margulis, Ingvild Odsbu, Kwame Appenteng, Cheryl Enger, Morten Olesen

المصدر: Phiri, K, Hallas, J, Linder, M, Margulis, A, Suehs, B, Arana, A, Bahmanyar, S, Hoffman, V, Enger, C, Horter, L, Odsbu, I, Olesen, M, Perez-Gutthann, S, Kristiansen, N S, Appenteng, K, de Vogel, S & Seeger, J 2021, ' A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder ', Current Medical Research and Opinion, vol. 37, no. 5, pp. 867-877 . https://doi.org/10.1080/03007995.2021.1891035Test
the Mirabegron PMR-PASS study group 2021, ' A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder ', Current Medical Research and Opinion . https://doi.org/10.1080/03007995.2021.1891035Test

مصطلحات موضوعية: Male, medicine.medical_specialty, Urology, neoplasms, overactive, Muscarinic Antagonists, 030204 cardiovascular system & hematology, 03 medical and health sciences, 0302 clinical medicine, Neoplasms, medicine, Humans, In patient, 030212 general & internal medicine, antimuscarinics, Urinary bladder, business.industry, Urinary Bladder, Overactive, Incidence (epidemiology), Cancer, General Medicine, medicine.disease, PASS, mirabegron, Thiazoles, medicine.anatomical_structure, Treatment Outcome, Urological Agents, Acetanilides, Female, Treatments for overactive bladder, Mirabegron, business, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e16fdb16219dfcf888757ab899a0540Test
https://pubmed.ncbi.nlm.nih.gov/33591859Test

المؤلفون: John D. Seeger, Stefan de Vogel, Andrea V. Margulis, Susana Perez Gutthann, Jesper Hallas, Kwame Appenteng, Brandon T. Suehs, Alejandro Arana, Morten S. Olesen, Nina Sahlertz Kristiansen, Cheryl Enger, Libby Horter, Veena Hoffman, Yihua Xu, Ingvild Odsbu, Marie Linder

المصدر: Circulation. 142

مصطلحات موضوعية: Agonist, medicine.medical_specialty, business.industry, medicine.drug_class, Placebo, medicine.disease, Clinical trial, Blood pressure, Physiology (medical), Internal medicine, medicine, Cardiology, Myocardial infarction, Treatments for overactive bladder, Cardiology and Cardiovascular Medicine, Mirabegron, business, Stroke, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::1db0f2fc25a27e7aa2733f01192df96aTest
https://doi.org/10.1161/circ.142.suppl_3.13154Test

المؤلفون: Kelesitse Phiri (10151892), Jesper Hallas (494248), Marie Linder (5797838), Andrea Margulis (3496163), Brandon Suehs (5097140), Alejandro Arana (5797841), Shahram Bahmanyar (620236), Veena Hoffman (6845507), Cheryl Enger (6197636), Libby Horter (7927296), Ingvild Odsbu (257660), Morten Olesen (10151895), Susana Perez-Gutthann (3496169), Nina Sahlertz Kristiansen (5797850), Kwame Appenteng (5797859), Stefan de Vogel (4063141), John Seeger (3566930)

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Immunology, Cancer, Urinary bladder, overactive, mirabegron, antimuscarinics, neoplasms, PASS

العلاقة: https://figshare.com/articles/dataset/A_study_of_cancer_occurrence_in_users_of_mirabegron_and_antimuscarinic_treatments_for_overactive_bladder/14043702Test

الإتاحة: https://doi.org/10.6084/m9.figshare.14043702.v1Test

المؤلفون: Stefan de Vogel, Irene D. Bezemer, Daniel Dedman, Fabian Hoti, Noah Jamie Robinson, Daniel Prieto-Alhambra, Fernie J. A. Penning-van Beest, Helen P Booth, Minna Vehkala, Kwame Appenteng, Edith M. Heintjes, Ying He, Elisabeth Smits

المصدر: Clinical Epidemiology

مصطلحات موضوعية: medicine.medical_specialty, Epidemiology, direct healthcare professional communication, drug utilisation study, 030204 cardiovascular system & hematology, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Clinical Epidemiology, 030212 general & internal medicine, interrupted time series analysis, Healthcare data, risk minimization, Original Research, business.industry, Medical record, medicine.disease, Blood pressure, Overactive bladder, Population study, Observational study, business, Mirabegron, Cohort study, medicine.drug

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbbb49f8a966e3ab55144813c4da80c8Test
https://www.dovepress.com/evaluating-the-effectiveness-of-an-additional-risk-minimization-measur-peer-reviewed-article-CLEPTest

المؤلفون: Margaret Oluka, Ariel E. Arias, Johanita Burger, Kwame Appenteng, Amos Massele, Laura Horne, Brian Godman, Joseph O Fadare, Abraham G. Hartzema, Maribel Salas, Luciane Cruz Lopes, Miriam García Estrada, Ulf Bergman, Daniel Ankrah, Björn Wettermark, Macarius Donneyong, Carmen Vilaseca, Martha S. Lubbe, Raquel Herrera Comoglio, Diana L. Gómez-Galicia, Luis Alesso, Elisangela da Costa Lima, Olayinka O Ogunleye, Jorgelina Bernet, Ilse Truter

المصدر: Pharmacoepidemiology and drug safetyREFERENCES. 29(11)

مصطلحات موضوعية: Drug Utilization, Economic growth, Motivation, Latin Americans, Epidemiology, business.industry, media_common.quotation_subject, Language barrier, Demographic transition, 030226 pharmacology & pharmacy, Literacy, RS, 03 medical and health sciences, Politics, 0302 clinical medicine, Latin America, Health care, Medicine, Humans, Pharmacology (medical), Health education, 030212 general & internal medicine, business, media_common

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00a5efe8f921e1dcfd16de9018ab271bTest
https://pubmed.ncbi.nlm.nih.gov/32419226Test

المؤلفون: Milbhor D’Silva, Kwame Appenteng, Jason C. Simeone, Beth L. Nordstrom, Samuel Huse

المصدر: Drugs-Real World Outcomes

مصطلحات موضوعية: medicine.medical_specialty, business.industry, Proportional hazards model, Hazard ratio, 030204 cardiovascular system & hematology, medicine.disease, Mini sentinel, Confidence interval, 03 medical and health sciences, 0302 clinical medicine, Overactive bladder, Internal medicine, Medicine, Pharmacology (medical), 030212 general & internal medicine, Original Research Article, business, Mirabegron, Oxybutynin, Stroke, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a24426b1bd3d54c16d8b6c9d672ed0eTest
http://europepmc.org/articles/PMC5825387Test

المؤلفون: Stefan de Vogel, Andrea V. Margulis, Alejandro Arana, Libby Horter, Susana Perez-Gutthann, Kwame Appenteng, Kelesitse Phiri, Shahram Bahmanyar, Jesper Hallas, Morten S. Olesen, Nina Sahlertz Kristiansen, John D. Seeger, Marie Linder, Cheryl Enger, Ingvild Odsbu, Brandon T. Suehs

المصدر: The Journal of Urology. 203:e910-e911

مصطلحات موضوعية: Agonist, medicine.medical_specialty, business.industry, medicine.drug_class, Urology, Cancer, medicine.disease, Overactive bladder, Medicine, Treatments for overactive bladder, business, Mirabegron, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::558b6ac186b66a3ee986d4f7837f7a00Test
https://doi.org/10.1097/ju.0000000000000931.010Test